期刊文献+

荧光定量PCR技术检测流产组织中人细小病毒B19的感染 被引量:1

Determination of human parvovirus B19(HPV B19) in abortion tissues by fluorescent quantitative PCR
下载PDF
导出
摘要 目的比较荧光定量PCR(FQ-PCR)与PCR在检测自然流产组织人细小病毒B19(HPV B19)感染临床应用中的优劣。方法收集自然流产病例41例以FQ-PCR与PCR分别进行流产组织的HPV B19 DNA检测。结果FQ-PCR HPV B19 DNA的阳性检出率为51.20%,PCR HPV B19 DNA的阳性检出率为36.56%,两种方法的阳性检出率经统计学检验具有统计学差异(P<0.05)。结论FQ-PCR的灵敏性较PCR高,能更加清楚地了解HPV B19在体内的存在状态。 Objective To compare the advantages and disadvantages of fluorescent quantitative PIER (FQ-PCR) and polymerase chain reaction (PCR) in determining human parvovirus B19 (HPV B19) in abortion tissues. Methods Tested tissues from 41 cases of unexplained spontaneous abortion were studied using FQ-PCR and PCR assay for HPV B19. Results The prevalence of HPV B19 DNA was 51.20 % by FQ-PCR and 36.56% by PCR in the sera of abortion women, respectively. There was significant difference between them(P 〈 0.05). Conclusion The results suggest that FQ-PCR is more sensitive and efficient than traditional PCR for deteting HPV B19 from abortion tissues.
出处 《山西医科大学学报》 CAS 2008年第1期24-26,共3页 Journal of Shanxi Medical University
关键词 自然流产 人类细小病毒B19 荧光定量PCR 聚合酶链反应 spontaneous abortion human parvovirus B19 fluorescent quantitative PCR polymerase chain reaction
  • 相关文献

参考文献5

  • 1Hiroshi C,Kiyoshi I,Hitoshi N,et al.Clinical manifestations and outcome of parvovirus B19 infection during pregnancy in Japan[J].Exp Med,2006,209(3):277-283.
  • 2Amanda C,Sean D.Advances in the biology,diagnosis and hostpathogen interactions of parvovirus B19[J].Med Microbiol,2004,53:459-475.
  • 3姜泊,张亚历,周殿元,等.分子生物学常用实验方法[M].1版.北京:人民军医出版社,2000.66-68.
  • 4祝丙华,许金波.人细小病毒B19检测方法研究进展[J].国际病毒学杂志,2006,13(1):16-19. 被引量:5
  • 5Takano T,Yamada K.Quantification of human parvovirus B19 DNA by real-time polymerase chain reaction[J].Pediatr Int,2007,49(2):459-462.

二级参考文献19

  • 1Heegaard ED,Brown KE.Human parvovirus B19.Clin Microbiol Rev.2002 Jul; 15(3):485-505.
  • 2Koppelman MH,Cuypers HT,Emrich T,Zaaijer HL.Quantitative real-time detection of parvovirus B19 DNA in plasma.Transfusion.2004 Jan;44(1):97-103.
  • 3Setubal S,Cardias CA,de Oliveira SA,do Nascimento JP.Viremic blood donor found by a rapid screening method in a season of high human parvovirus B19 activity in Niteroi,Rio de Janeiro,Brazil.Mem Inst Oswaldo Cruz.2004 Feb;99(1):95-99.
  • 4Caillet-Fauquet P,Di Giambattista M,Draps ML,Sandras F,Branckaert T,de Launoit Y,Laub R.Continuous-flow UVC irradiation:a new,effective,protein activity-preserving system for inactivating bacteria and viruses,including erythrovirus B19.J Virol Methods.2004 Jun 15;118(2):131-139.
  • 5E.Manarest,G.Gallinella,S.Venturoli,M.Zerbini,MonicaMusiani.Detection of parvovirus B19 IgG:choice of antigens and serological tests.Journal of Clinical Virology.2004 Jun 29(1):51-53.
  • 6Harder TC,Hufnagel M,Zahn K,Beutel K,Schmitt HJ,Ullmann U,Rautenberg P.New LightCycler PCR for rapid and sensitive quantification of parvovirus B19 DNA guides therapeutic decisionmaking in relapsing infections.J Clin Microbiol.2001 Dec; 39(12):4413-4419.
  • 7Brown KE,Young NS.Parvovirus B19 in human disease.Annu Rev Med.1997;48:59-67.
  • 8Flunker G,Peters A,Wiersbitzky S,Modrow S,Seidel W.Persistent parvovirus B19 infections in immunocompromised children.Med Microbiol Immunol (Berl).1998 Mar; 186(4):189-194.
  • 9Kerr S,O'Keeffe G,Kilty C,Doyle S.Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG.J Med Virol.1999 Feb;57(2):179-185.
  • 10Zerbini M,Musiani M.Human parvovirus.In:Muraay PR,Baron E J,Pfaller MA,Tenover FC,Yolken RH,editors.Manual of Clinical Microbiology.7th edn.Washington,DC:ASM Press; 1999,p.1089-1098.

共引文献5

同被引文献10

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部